Scoop has an Ethical Paywall
Licence needed for work use Start Free Trial
 

PHARMAC - Latest News [Page 22]

Prescribing decline a healthy trend

Tuesday, 13 May 2008, 10:39 am | PHARMAC

A continuing decline in prescription figures for the most commonly used antibiotics is a healthy sign, says PHARMAC’s Medical Director Dr Peter Moodie. PHARMAC has today launched the 11th annual Wise Use of Antibiotics campaign, aimed at encouraging ... More >>

Herceptin consultation underway

Monday, 5 May 2008, 1:04 pm | PHARMAC

PHARMAC has today begun consulting on a proposal to decline funding for 12 months’ treatment for HER2 positive early breast cancer with Herceptin. More >>

Matthew Brougham appointed PHARMAC’s CEO

Wednesday, 16 April 2008, 11:33 am | PHARMAC

The appointment confirms Matthew Brougham in the position he has held in an interim capacity since July 2006. More >>

New PHARMAC website designed to meet users’ needs

Monday, 14 April 2008, 9:34 am | PHARMAC

A re-designed PHARMAC website is aimed at helping people better understand the Government drug-funding agency’s work, says Corporate Manager Peter Alsop. More >>

Herceptin Court judgement reassuring

Thursday, 3 April 2008, 2:37 pm | PHARMAC

Today's High Court judgement on Herceptin gives New Zealanders significant reassurances about PHARMAC's processes and decision making, says PHARMAC’s acting chief executive Matthew Brougham. More >>

PHARMAC Working For Flexibility In Brand Changes

Thursday, 20 December 2007, 5:01 pm | PHARMAC

PHARMAC will keep working to find a practicable mechanism to provide some flexibility in its sole supply tender, says Manager Funding and Procurement Steffan Crausaz. More >>

PHARMAC well placed to respond to Medicines NZ

Friday, 14 December 2007, 3:07 pm | PHARMAC

PHARMAC has welcomed the release of Medicines New Zealand – a new strategy for the medicines system – and is well placed to act on its findings. More >>

“Good housekeeping”is all about the benefits

Thursday, 29 November 2007, 3:55 pm | PHARMAC

“Good housekeeping” delivers significantly more health benefits to New Zealanders than similar sized budgets would provide in possibly any other country, says PHARMAC’s Acting Chief Executive Matthew Brougham. More >>

Optimal use of medicines a key challenge for 2008

Thursday, 29 November 2007, 3:55 pm | PHARMAC

The challenge of getting the best from funded medicines – “optimal use” – is looming as a key issue for 2008. In launching its 2007 Annual Review, Government drug funder PHARMAC says there is much to gain for the health system from a stronger ... More >>

NZers getting more funded prescriptions than ever

Thursday, 29 November 2007, 11:45 am | PHARMAC

Prescriptions for funded medicines have risen to an all-time high, figures from Government drug-funder PHARMAC show. More >>

Step forward for cancer treatment

Wednesday, 21 November 2007, 4:16 pm | PHARMAC

Cancer treatment is taking a significant step forward with PHARMAC and District Health Boards approving funding for three further cancer medicines. More >>

Step forward for cancer treatment

Wednesday, 21 November 2007, 10:23 am | PHARMAC

Cancer treatment is taking a significant step forward with PHARMAC and District Health Boards approving funding for three further cancer medicines. More >>

Committed to action on Stakeholder Survey

Monday, 12 November 2007, 11:48 am | PHARMAC

A survey of stakeholders of the Government drug-funding agency PHARMAC has identified areas for PHARMAC to work on to improve how it is perceived, acting chief executive Matthew Brougham says. More >>

BSA Herceptin decision underlines need for balance

Monday, 1 October 2007, 10:00 am | PHARMAC

PHARMAC is welcoming the outcome of a complaint it made to the Broadcasting Standards Authority about an unbalanced and inaccurate TV3 60 Minutes programme. More >>

Ritalin SR to be funded for some patients

Thursday, 27 September 2007, 1:43 pm | PHARMAC

PHARMAC is providing funded access to the Ritalin SR brand of methylphenidate for those people who have experienced clinical difficulties in changing to Rubifen SR, another brand of methylphenidate. More >>

Christchurch GP welcomed onto PHARMAC Board

Tuesday, 25 September 2007, 11:18 am | PHARMAC

PHARMAC Board chairman Richard Waddel is welcoming the appointment of Christchurch GP David Kerr to the Board of the Government drug-funding agency. More >>

Step forward for access to off-patent medicines

Friday, 14 September 2007, 3:17 pm | PHARMAC

People will be able to more easily access some off-patent medicines, if changes proposed by Government drug-funding agency PHARMAC are adopted. More >>

Corrected data on antidepressant prescribing

Thursday, 13 September 2007, 9:40 am | PHARMAC

PHARMAC has completed further analysis of data on the prescribing of antidepressants, and revised down very considerably the numbers of preschool children being prescribed antidepressants. More >>

New breast cancer drug funded

Monday, 13 August 2007, 9:24 am | PHARMAC

Women with breast cancer have another funded drug treatment available, with the aromatase inhibitor drug exemestane (Aromasin) funded from August 1. Aromatase inhibitors can help block the growth of hormone-dependent tumours by lowering the amount of the ... More >>

PHARMAC funds another antipsychotic drug

Friday, 10 August 2007, 11:12 am | PHARMAC

People with schizophrenia and related psychoses have a new funded treatment available. More >>

   

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL